Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. - Wikidata - awgldk - TriplyDB

Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer.

Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer.

http://www.wikidata.org/entity/Q34308435

about

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice DAB2IP in cancer Ca2+-dependent monomer and dimer formation switches CAPRI Protein between Ras GTPase-activating protein (GAP) and RapGAP activities.Tumor suppressor protein DAB2IP participates in chromosomal stability maintenance through activating spindle assembly checkpoint and stabilizing kinetochore-microtubule attachments.Negative regulation of DAB2IP by Akt and SCFFbw7 pathways A common genetic variant (97906C>A) of DAB2IP/AIP1 is associated with an increased risk and early onset of lung cancer in Chinese males.The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression network Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer.Downregulation of DAB2IP promotes mesenchymal-to-neuroepithelial transition and neuronal differentiation of human mesenchymal stem cells.Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.Differential Regulation of RasGAPs in Cancer.Epigenetic inactivation of galanin receptor 1 in head and neck cancer.Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer.Expression of mouse Dab2ip transcript variants and gene methylation during brain development.Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers.A Novel Monoclonal Antibody Against Human DAB2IP.AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis.Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer.The mechanism of DAB2IP in chemoresistance of prostate cancer cells.Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapy The RasGAP gene, RASAL2, is a tumor and metastasis suppressor Smurf1 regulation of DAB2IP controls cell proliferation and migration Nonredundant functions for Ras GTPase-activating proteins in tissue homeostasis.Breast- and salivary gland-derived adenoid cystic carcinomas: potential post-transcriptional divergencies. A pilot study based on miRNA expression profiling of four cases and review of the potential relevance of the findings.Ras activation revisited: role of GEF and GAP systems.Cathepsin-B-mediated cleavage of Disabled-2 regulates TGF-β-induced autophagy.Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1.Amyloid β regulates the expression and function of AIP1.Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.The role of DAB2IP in androgen receptor activation during prostate cancer progression.Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour.

P2860

Q24295609-0999A22D-9F96-4FC7-BDA8-D162085AE855 Q24299235-C9212681-FDA8-41AB-9439-D09FA6D7B8D1 Q24316141-812086C4-DFE7-4210-A4F5-4225091C1DE6 Q24318212-C8302445-37B7-48FA-901D-68B4E30A57B0 Q26776456-25F93F7E-E007-4E1A-822D-391F470EECA2 Q30500617-EC148189-6F2A-45F5-81B3-6DBDBB98CE53 Q30822011-27931DA2-E1E5-4A70-9585-1A14BF08BAD1 Q33917635-94E6A92E-7267-4F38-87F0-FBB8C1E64EF2 Q34064865-01AB048D-D69E-441C-B287-13FF4681D567 Q34227747-61C20758-C600-4DCD-9CD2-A29C68E2D6AB Q34318239-E3B74E5A-EF1D-46E0-B0A3-786E0490BDF9 Q34409667-20EC6B90-2D89-42CE-89CD-237CDF46F6C9 Q34695260-1812D6F3-9574-440B-BFAB-F200ED7207C4 Q35000947-10E6B3B8-2C13-48F8-823E-DE355DBF7E5B Q35051774-68CF4A4A-FD9F-45D1-BC5D-7C5723925DB0 Q35083732-A43EF0B0-C4EA-4ABF-9260-877013C73AE3 Q35298275-AF6A31FC-F097-4152-A748-328100C7EC9D Q35723937-FE47DE36-8605-4B64-B3A7-38824E43DFA2 Q35759432-519C381D-E479-4E4B-8E13-4AE535C28D05 Q35927921-1C8468C7-BB83-4FD7-88A1-30BA14207C68 Q36011799-9E9EC5B1-444D-4DD1-B9B8-5153129E32B0 Q36021172-631309E5-CFEA-4AFF-BFBC-E3A697119F3F Q36275433-15C91C12-0C09-44A0-9B6D-2A35FA71867D Q36413800-9C88A87F-50DC-4175-9F0A-2AC02E0028DC Q36725756-95558775-6364-4AC9-8D7F-995FA488FB64 Q37084855-3369C542-C045-487D-8341-2EA027E3D1BB Q37293348-31B76C62-4A84-49A8-A3A5-67B04F25A293 Q37295581-8F966BF0-F1C5-4ED3-B017-8BF319C361C9 Q38084894-4F67C0C8-0324-461A-BB3E-AEA471ED4FBC Q38252816-79CBCE1A-993A-4348-A334-899FE5BBDAE0 Q38381506-43880EFF-7D3F-4BF3-8D89-0A4BC9D68DF8 Q38758877-ACA14452-D004-4240-BADC-898D2A4BC7A3 Q38794217-E54F2EAF-F706-42FA-B6E2-0D4BFFF54191 Q38920371-44B53197-7C7F-4D43-AEC8-8A97B8ECB3CE Q38973690-DB78A518-9698-463C-88EC-6E3B6F7A0201 Q38978955-2F990AA5-336C-4514-B756-EEAE62137C63 Q39012136-ABA88C14-311F-4D57-B5F6-5A06DD70CB4D Q39162930-44635DAD-3BF5-4880-A147-4BAE4E9D03E9 Q39428754-178FFDA7-5523-45DE-A2AD-15199EACC00B Q40446210-6A0B2077-9AF7-4760-8CFB-E5B048205856

P2860

Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer.

http://www.wikidata.org/entity/Q34308435

description

2004 nî lūn-bûn

@nan

2004 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մարտին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Aberrant promoter methylation ...... DAB2IP) gene in breast cancer.

@ast

Aberrant promoter methylation ...... DAB2IP) gene in breast cancer.

@en

Aberrant promoter methylation in human DAB2 interactive protein

@nl

type

label

Aberrant promoter methylation ...... DAB2IP) gene in breast cancer.

@ast

Aberrant promoter methylation ...... DAB2IP) gene in breast cancer.

@en

Aberrant promoter methylation in human DAB2 interactive protein

@nl

prefLabel

Aberrant promoter methylation ...... DAB2IP) gene in breast cancer.

@ast

Aberrant promoter methylation ...... DAB2IP) gene in breast cancer.

@en

Aberrant promoter methylation in human DAB2 interactive protein

@nl

P1433

Q34308435-CD3762B9-7D58-48D4-BF0E-EE72B29B34CC

P1476

Q34308435-BADE3D1A-8484-40ED-A3C0-63F0FA7C823B

P2093

Q34308435-360D7F6F-B616-478E-9E5C-78E8B50E1B41

Q34308435-430D8E90-8906-4B1C-9345-18E9F38B6B14

Q34308435-4C73920C-A389-43BB-8421-35EE0B7CFE64

Q34308435-8F7A4B48-18CA-4DDB-806E-557609DCE49C

Q34308435-95E77B7D-59AE-43CD-A699-7E2F83FF605F

Q34308435-A094BB3D-30C7-4D44-9B79-B1C17B3122BB

Q34308435-A6702C68-0BE8-4076-A941-38B12A4E34BE

Q34308435-AAF6D618-4F87-4C62-928B-A1ABC2A8D5B8

Q34308435-B97AB88D-57B2-4D26-99AF-82BBA27EEE52

Q34308435-E4F43391-283E-4082-9D92-A840F247B09D

P304

Q34308435-9F8E5FD7-E844-4C68-A345-E8A111453242

P31

Q34308435-E2CEBE64-1577-4C80-B253-C8B8E7E60233

P356

Q34308435-E10E67B9-6074-470A-9A48-1846154ED8B8

P407

Q34308435-AF50CBB8-3EC8-421F-80DA-29ECF3925883

P433

Q34308435-4AD0FD36-496C-402C-A2B5-80511137ED98

P478

Q34308435-6909F861-D00C-4458-87CF-56844F4C3854

P577

Q34308435-C97C8D3A-2B5D-49E2-B485-2D974C3A6BED

P698

Q34308435-342EC7CC-F83C-4D48-8EF7-D6C8064ABB47

P356

1078-0432.CCR-03-0236

P1433

Clinical Cancer Research

P1476

Aberrant promoter methylation ...... DAB2IP) gene in breast cancer.

@en

P2093

Adi F Gazdar

http://www.w3.org/2001/XMLSchema#string

Hideaki Dote

http://www.w3.org/2001/XMLSchema#string

Hiroyoshi Doihara

http://www.w3.org/2001/XMLSchema#string

Hong Chen

http://www.w3.org/2001/XMLSchema#string

Jer-Tsong Hsieh

http://www.w3.org/2001/XMLSchema#string

Kazunori Tsukuda

http://www.w3.org/2001/XMLSchema#string

Makoto Suzuki

http://www.w3.org/2001/XMLSchema#string

Mamoru Ouchida

http://www.w3.org/2001/XMLSchema#string

Masaaki Yano

http://www.w3.org/2001/XMLSchema#string

Nobuyoshi Shimizu

http://www.w3.org/2001/XMLSchema#string

P304

2082-2089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-03-0236

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15041729

http://www.w3.org/2001/XMLSchema#string